Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Unrealistic expectations.....Al
32
Oct 07, 2013 11:19AM
20
Oct 07, 2013 11:36AM
7
Oct 07, 2013 11:52AM

OTC and Brand Name Recognition? You're kidding right?

OTC: We simply don't qualify for nasdaq, reverse split would be idiotic considering our balance sheet.

Brand Recognition: What brand would that be? We don't produce anything.

When the balance sheet changes then and only then can they attempt what you suggest.

Check below and especially check cash on hand and cash flows.......

Financial Highlights

Fiscal Year
Fiscal Year Ends: May 31
Most Recent Quarter (mrq): May 31, 2013
Profitability
Profit Margin (ttm): N/A
Operating Margin (ttm): N/A
Management Effectiveness
Return on Assets (ttm): -10.43%
Return on Equity (ttm): 14.24%
Income Statement
Revenue (ttm): N/A
Revenue Per Share (ttm): N/A
Qtrly Revenue Growth (yoy): N/A
Gross Profit (ttm): N/A
EBITDA (ttm)6: -1.38M
Net Income Avl to Common (ttm): 1.08M
Diluted EPS (ttm): 0.00
Qtrly Earnings Growth (yoy): N/A
Balance Sheet
Total Cash (mrq): 7.77M
Total Cash Per Share (mrq): 0.02
Total Debt (mrq): 0.00
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 28.95
Book Value Per Share (mrq): 0.02
Cash Flow Statement
Operating Cash Flow (ttm): -1.01M
Levered Free Cash Flow (ttm): -911.82K
Share
New Message
Please login to post a reply